Literature DB >> 26557948

Clinical and biological significance of precursor lesions of intrahepatic cholangiocarcinoma.

Mark Ettel1, Ogechukwu Eze1, Ruliang Xu1.   

Abstract

Cholangiocarcinoma (CC) is primarily a malignant tumor of older adults most prevalent in Southeast Asia, where liver fluke infestation is high. However the etiology in western countries is unknown. Although the incidence of extrahepatic cholangiocarcinoma has remained constant, incidence of intrahepatic CC (ICC) which differs in morphology, pathogenesis, risk factors, treatment and prognosis is increasing. While this increase is associated with hepatitis C virus infection, chronic nonalcoholic liver disease, obesity, and smoking, the pathogenesis of ICC and molecular alterations underlying the carcinogenesis are not completely elucidated. Benign biliary lesions such as biliary intraepithelial neoplasia, intraductal papillary neoplasm of the bile duct, von Meyenburg complex or bile duct hamartoma, and bile duct adenoma have been associated with ICC. For each of these entities, evidence suggests or supports a role as premalignant lesions. This article summarized the important biological significance of the precursor lesions of ICC and the molecular mechanisms that may be involved in intrahepatic cholangiocarcinogenesis.

Entities:  

Keywords:  Bile duct adenoma; Intraductal papillary neoplasm of the bile duct; Intraepithelial neoplasia; Intrahepatic cholangiocarcinoma; Von Meyenburg complex or bile duct hamartoma

Year:  2015        PMID: 26557948      PMCID: PMC4635141          DOI: 10.4254/wjh.v7.i25.2563

Source DB:  PubMed          Journal:  World J Hepatol


  72 in total

1.  The so-called bile duct adenoma is a peribiliary gland hamartoma.

Authors:  P S Bhathal; N R Hughes; Z D Goodman
Journal:  Am J Surg Pathol       Date:  1996-07       Impact factor: 6.394

2.  Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.

Authors:  Daniela Sia; Yujin Hoshida; Augusto Villanueva; Sasan Roayaie; Joana Ferrer; Barbara Tabak; Judit Peix; Manel Sole; Victoria Tovar; Clara Alsinet; Helena Cornella; Brandy Klotzle; Jian-Bing Fan; Christian Cotsoglou; Swan N Thung; Josep Fuster; Samuel Waxman; Juan Carlos Garcia-Valdecasas; Jordi Bruix; Myron E Schwartz; Rameen Beroukhim; Vincenzo Mazzaferro; Josep M Llovet
Journal:  Gastroenterology       Date:  2013-01-04       Impact factor: 22.682

3.  Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?

Authors:  Flavio G Rocha; Hwajeong Lee; Nora Katabi; Ronald P DeMatteo; Yuman Fong; Michael I D'Angelica; Peter J Allen; David S Klimstra; William R Jarnagin
Journal:  Hepatology       Date:  2012-08-27       Impact factor: 17.425

4.  Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver.

Authors:  A Tannapfel; L Weinans; F Geissler; A Schütz; A Katalinic; F Köckerling; J Hauss; C Wittekind
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

5.  Cholangiocarcinoma arising in bile duct adenoma with focal area of bile duct hamartoma.

Authors:  T Hasebe; M Sakamoto; K Mukai; N Kawano; M Konishi; M Ryu; S Fukamachi; S Hirohashi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract.

Authors:  Susan C Abraham; Jae-Hyuk Lee; Ralph H Hruban; Pedram Argani; Emma E Furth; Tsung-Teh Wu
Journal:  Hum Pathol       Date:  2003-09       Impact factor: 3.466

7.  KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas.

Authors:  Maylee Hsu; Motoko Sasaki; Saya Igarashi; Yasunori Sato; Yasuni Nakanuma
Journal:  Cancer       Date:  2013-01-18       Impact factor: 6.860

Review 8.  Proposal of a new disease concept "biliary diseases with pancreatic counterparts". Anatomical and pathological bases.

Authors:  Yasuni Nakanuma; Kenichi Harada; Motoko Sasaki; Yasunori Sato
Journal:  Histol Histopathol       Date:  2013-10-10       Impact factor: 2.303

9.  Biliary neoplasia with extensive intraductal spread associated with liver cirrhosis: a hitherto unreported variant of biliary intraepithelial neoplasia.

Authors:  Shinichi Aishima; Yunosuke Nishihara; Eiji Tsujita; Kenichi Taguchi; Yuji Soejima; Akinobu Taketomi; Yasuharu Ikeda; Yoshihiko Maehara; Masazumi Tsuneyoshi
Journal:  Hum Pathol       Date:  2008-04-21       Impact factor: 3.466

10.  Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.

Authors:  Andrea Tannapfel; Florian Sommerer; Markus Benicke; Lars Weinans; Alexander Katalinic; Felix Geissler; Dirk Uhlmann; Johann Hauss; Christian Wittekind
Journal:  J Pathol       Date:  2002-08       Impact factor: 7.996

View more
  6 in total

Review 1.  Early detection of intrahepatic cholangiocarcinoma.

Authors:  Mami Hamaoka; Kazuto Kozaka; Osamu Matsui; Takahiro Komori; Takashi Matsubara; Norihide Yoneda; Kotaro Yoshida; Dai Inoue; Azusa Kitao; Wataru Koda; Toshifumi Gabata; Satoshi Kobayashi
Journal:  Jpn J Radiol       Date:  2019-08-01       Impact factor: 2.374

2.  Surgery is the preferred treatment for bile duct hamartomas.

Authors:  Xiao-Yu Yang; Hai-Bo Zhang; Bin Wu; Ai-Jun Li; Xiao-Hui Fu
Journal:  Mol Clin Oncol       Date:  2017-07-31

Review 3.  Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma.

Authors:  Taek Chung; Young Nyun Park
Journal:  Front Med (Lausanne)       Date:  2022-03-31

4.  Biliary Intraepithelial Neoplasia in Non-biliary Cirrhosis-Report From 100 Explanted Livers: A Single Center Experience.

Authors:  Maryam Zarei; Alireza Shasaeefar; Kurosh Kazemi; Masoud Dehghani; Seyed-Ali Malekhosseini; Bita Geramizadeh
Journal:  Clin Pathol       Date:  2019-09-17

Review 5.  Molecular Pathogenesis of Cholangiocarcinoma.

Authors:  Peter L Labib; George Goodchild; Stephen P Pereira
Journal:  BMC Cancer       Date:  2019-02-28       Impact factor: 4.430

Review 6.  Precursor Lesions of Cholangiocarcinoma: A Clinicopathologic Review.

Authors:  Bita Geramizadeh
Journal:  Clin Pathol       Date:  2020-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.